Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 3 , Pages 423-436 , September 2008

Sternal wound infections

  • William J. Mauermann, MD (Clinical Instructor in Anesthesiology)

      Affiliations

    • Corresponding Author InformationCorresponding Author. Department of Anesthesiology, 200 First Street SW, MB 2-752, Rochester, MN 55905, United States. Tel.: +1 507 255 4240; Fax: +1 507 255 6463.

References 

  1. Bitkover CY, Gardlund B. Mediastinitis after cardiovascular operations: a case-control study of risk factors. Annals of Thoracic Surgery. 1998;65:36–40
  2. De Feo M, Renzulli A, Ismeno G, et al. Variables predicting adverse outcome in patients with deep sternal wound infection. Annals of Thoracic Surgery. 2001;71:324–331
  3. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Annals of Thoracic Surgery. 1996;61:1030–1036
  4. Jonkers D, Elenbaas T, Terporten P, et al. Prevalence of 90-days postoperative wound infections after cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2003;23:97–102
  5. Munoz P, Menasalvas A, Bernaldo de Quiros JC, et al. Postsurgical mediastinitis: a case-control study. Clinical Infectious Diseases. 1997;25:1060–1064
  6. Salehi Omran A, Karimi A, Ahmadi SH, et al. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infectious Disease. 2007;7:112
  7. Sharma M, Berriel-Cass D, Baran J. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period. Infection Control and Hospital Epidemiology. 2004;25:468–471
  8. Wouters R, Wellens F, Vanermen H, et al. Sternitis and mediastinitis after coronary artery bypass grafting. Analysis of risk factors. Texas Heart Institute Journal. 1994;21:183–188
  9. Mauermann WJ, Nemergut EC. The anesthesiologist's role in the prevention of surgical site infections. Anesthesiology. 2006;105:413–421quiz 39–40
  10. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  11. Toumpoulis IK, Anagnostopoulos CE, Derose JJ, et al. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest. 2005;127:464–471
  12. Risk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. The Journal of Thoracic and Cardiovascular Surgery. 1996;111:1200–1207
  13. Centofanti P, Savia F, La Torre M, et al. A prospective study of prevalence of 60-days postoperative wound infections after cardiac surgery. An updated risk factor analysis. The Journal of Cardiovascular Surgery. 2007;48:641–646
  14. Guidelines and Indications For Coronary Artery Bypass Surgery. A Report Of The American College of Cardiolgy/ American Heart AssociationTask Force on Assessment of Diagnositc and Therapeutic Cardiovascular Procedures. Journal of the American College of Surgeons. 1991;17:543–589
  15. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. The New England Journal of Medicine. 1986;314:1–6
  16. Arnold M. The surgical anatomy of sternal blood supply. The Journal of Thoracic and Cardiovascular Surgery. 1972;64:596–610
  17. Seyfer AE, Shriver CD, Miller TR, et al. Sternal blood flow after median sternotomy and mobilization of the internal mammary arteries. Surgery. 1988;104:899–904
  18. Grossi EA, Esposito R, Harris LJ, et al. Sternal wound infections and use of internal mammary artery grafts. The Journal of Thoracic and Cardiovascular Surgery. 1991;102:342–346discussion 6–7
  19. Hazelrigg SR, Wellons HA, Schneider JA, et al. Wound complications after median sternotomy. Relationship to internal mammary grafting. The Journal of Thoracic and Cardiovascular Surgery. 1989;98:1096–1099
  20. Kouchoukos NT, Wareing TH, Murphy SF, et al. Risks of bilateral internal mammary artery bypass grafting. Annals of Thoracic Surgery. 1990;49:210–217discussion 7–9
  21. Galbut DL, Traad EA, Dorman MJ, et al. Seventeen-year experience with bilateral internal mammary artery grafts. Annals of Thoracic Surgery. 1990;49:195–201
  22. He GW, Ryan WH, Acuff TE, et al. Risk factors for operative mortality and sternal wound infection in bilateral internal mammary artery grafting. The Journal of Thoracic and Cardiovascular Surgery. 1994;107:196–202
  23. Loop FD, Lytle BW, Cosgrove DM, et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Annals of Thoracic Surgery. 1990;49:179–186discussion 86–7
  24. Filsoufi F, Rahmanian PB, Castillo JG, et al. Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation. The Journal of Heart and Lung Transplantation. 2007;26:1084–1090
  25. Carrier M, Perrault LP, Pellerin M, et al. Sternal wound infection after heart transplantation: incidence and results with aggressive surgical treatment. Annals of Thoracic Surgery. 2001;72:719–723discussion 23–4
  26. Senechal M, LePrince P, Tezenas du Montcel S, et al. Bacterial mediastinitis after heart transplantation: clinical presentation, risk factors and treatment. The Journal of Heart and Lung Transplantation. 2004;23:165–170
  27. Breyer RH, Mills SA, Hudspeth AS, et al. A prospective study of sternal wound complications. Annals of Thoracic Surgery. 1984;37:412–416
  28. Demmy TL, Park SB, Liebler GA, et al. Recent experience with major sternal wound complications. Annals of Thoracic Surgery. 1990;49:458–462
  29. Newman LS, Szczukowski LC, Bain RP, et al. Suppurative mediastinitis after open heart surgery. A case control study of risk factors. Chest. 1988;94:546–553
  30. Curtis JJ, Clark NC, McKenney CA, et al. Tracheostomy: a risk factor for mediastinitis after cardiac operation. Annals of Thoracic Surgery. 2001;72:731–734
  31. Force SD, Miller DL, Petersen R, et al. Incidence of deep sternal wound infections after tracheostomy in cardiac surgery patients. Annals of Thoracic Surgery. 2005;80:618–621discussion 21–2
  32. Rahmanian PB, Adams DH, Castillo JG, et al. Tracheostomy is not a risk factor for deep sternal wound infection after cardiac surgery. Annals of Thoracic Surgery. 2007;84:1984–1991
  33. Diehl JL, El Atrous S, Touchard D, et al. Changes in the work of breathing induced by tracheotomy in ventilator-dependent patients. American Journal of Respiratory and Critical Care Medicine. 1999;159:383–388
  34. Nieszkowska A, Combes A, Luyt CE, et al. Impact of tracheotomy on sedative administration, sedation level, and comfort of mechanically ventilated intensive care unit patients. Critical Care Medicine. 2005;33:2527–2533
  35. Rumbak MJ, Newton M, Truncale T, et al. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Critical Care Medicine. 2004;32:1689–1694
  36. Hubner N, Rees W, Seufert K, et al. Percutaneous dilatational tracheostomy done early after cardiac surgery–outcome and incidence of mediastinitis. The Thoracic and Cardiovascular Surgeon. 1998;46:89–92
  37. Banbury MK, Brizzio ME, Rajeswaran J, et al. Transfusion increases the risk of postoperative infection after cardiovascular surgery. Journal of the American College of Surgeons. 2006;202:131–138
  38. Soderquist B. Surgical site infections in cardiac surgery: microbiology. APMIS. 2007;115:1008–1011
  39. Gristina AG, Naylor P, Myrvik Q. Infections from biomaterials and implants: a race for the surface. Medical Progress Through Technology. 1988;14:205–224
  40. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Annals of Internal Medicine. 1991;114:101–106
  41. Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. The New England Journal of Medicine. 1959;260:1303–1308
  42. Williams RE, Jevons MP, Shooter RA, et al. Nasal staphylococci and sepsis in hospital patients. British Medical Journal. 1959;2:658–662
  43. Corbella X, Dominguez MA, Pujol M, et al. Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. European Journal of Clinical Microbiology & Infectious Diseases. 1997;16:351–357
  44. Jakob HG, Borneff-Lipp M, Bach A, et al. The endogenous pathway is a major route for deep sternal wound infection. European Journal of Cardio-Thoracic Surgery. 2000;17:154–160
  45. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. The Journal of Infectious Diseases. 1995;171:216–219
  46. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  47. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine. 2001;345:1359–1367
  48. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Annals of Thoracic Surgery. 1999;67:352–360discussion 60–2
  49. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Annals of Thoracic Surgery. 1997;63:356–361
  50. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Annals of Internal Medicine. 2007;146:233–243
  51. Hudson IR. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. The Journal of Hospital Infection. 1994;27:81–98
  52. Perl TM, Golub JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Annals of Pharmacotherapy. 1998;32:S7–S16
  53. Cimochowski GE, Harostock MD, Brown R, et al. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Annals of Thoracic Surgery. 2001;71:1572–1578discussion 8–9
  54. Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infection Control and Hospital Epidemiology. 1996;17:780–785
  55. Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. The Journal of Hospital Infection. 2006;64:162–168
  56. Pena C, Fernandez-Sabe N, Dominguez MA, et al. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization. The Journal of Hospital Infection. 2004;58:20–27
  57. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, et al. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. American Journal of Kidney Diseases. 2002;39:337–341
  58. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. The New England Journal of Medicine. 2002;346:1871–1877
  59. Kaiser AB, Kernodle DS, Barg NL, et al. Influence of preoperative showers on staphylococcal skin colonization: a comparative trial of antiseptic skin cleansers. Annals of Thoracic Surgery. 1988;45:35–38
  60. Byrne Dj NA, Cuschieri A. The value of whole body disinfection in the prevention of post-operative wound infection in clean and potentially contaminated surgery. Surgical Research Communications. 1992;12:43–52
  61. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database of Systematic Review. 2007;CD004985
  62. Sampathkumar P WA, Manahan JM, Mullany CJ, Thompson RL. Results of an Infection Control Program aimed at reducing Surgical Site Infections after Cardiac Surgery. Clinical Infectious Diseases. 2001;33:Abstract #240
  63. Brady LM, Thomson M, Palmer MA, et al. Successful control of endemic MRSA in a cardiothoracic surgical unit. Medical Journal of Australia. 1990;152:240–245
  64. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clinical Infectious Diseases. 2004;38:1706–1715
  65. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infection Control and Hospital Epidemiology. 1999;20:250–278quiz 79–80
  66. Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. The Journal of Thoracic and Cardiovascular Surgery. 2002;123:326–332
  67. Bolon MK, Morlote M, Weber SG, et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clinical Infectious Diseases. 2004;38:1357–1363
  68. Eklund AM. Prevention of sternal wound infections with locally administered gentamicin. APMIS. 2007;115:1022–1024
  69. Friberg O. Local collagen-gentamicin for prevention of sternal wound infections: the LOGIP trial. APMIS. 2007;115:1016–1021

☆ Disclosures: This review was funded with departmental and institutional support.

PII: S1521-6896(08)00032-3

doi: 10.1016/j.bpa.2008.04.003

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 3 , Pages 423-436 , September 2008

Article Tools

* Image Usage & Resolution